소동물 이미징 시장 규모는 2023년 93억 9,000만 달러로 평가되었으며, 2024년 99억 9,000만 달러에서 2032년에는 164억 4,000만 달러로 성장하며 예측 기간(2025-2032년) CAGR 6.42%로 나타날 전망입니다.
세계의 소동물 이미징 시장은 창약, 질병 연구, 생물학적 프로세스의 해명에 있어서 중요한 역할에 의해 현저한 성장을 이루고 있습니다. 치료 및 개인화 치료 전략의 개발을 촉진합니다. 고해상도 이미지 모달리티와 강화된 스캔 기능 등의 기술적 진보는 전임상 평가의 정확성과 효율을 향상시켜 시장 확대를 더욱 뒷받침하고 있습니다. 기술과 하이브리드 시스템의 통합은 소동물 이미징의 능력을 확대하고 연구 및 치료 개발의 진전에 필수적인 더 풍부하고 정확한 데이터 수집을 가능하게했습니다.
Small Animal Imaging Market size was valued at USD 9.39 Billion in 2023 and is poised to grow from USD 9.99 Billion in 2024 to USD 16.44 Billion by 2032, growing at a CAGR of 6.42% during the forecast period (2025-2032).
The global small animal imaging market is witnessing remarkable growth, driven by its vital role in drug discovery, disease research, and biological process understanding. This sector provides crucial insights into molecular and cellular mechanisms, facilitating the development of targeted therapies and personalized treatment strategies. The pharmaceutical and biotechnology industries significantly boost demand for these technologies, relying on preclinical studies to assess new drug candidates' safety and efficacy. Technological advancements, such as high-resolution imaging modalities and enhanced scanning capabilities, have further propelled market expansion, improving the accuracy and efficiency of preclinical assessments. Additionally, the integration of multimodal imaging techniques and hybrid systems has broadened small animal imaging's capabilities, allowing for richer and more precise data acquisition, crucial for advancing research and therapeutic development.
Top-down and bottom-up approaches were used to estimate and validate the size of the Small Animal Imaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Small Animal Imaging Market Segmental Analysis
Global Small Animal Imaging Market is segmented by modality, application, reagent and region. Based on modality, the market is segmented into optical imaging systems, nuclear imaging and other imaging modalities. Based on application, the market is segmented into monitoring drug treatment response, biodistribution studies, cancer cell detection, biomarkers, longitudinal studies and epigenetics. Based on reagents, the market is segmented into optical imaging reagents and nuclear imaging reagents. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Small Animal Imaging Market
The Small Animal Imaging market is primarily driven by the increasing focus on preclinical research within the pharmaceutical, biotechnology, and life sciences sectors. As the need for detailed investigations into diseases intensifies, the demand for sophisticated small animal imaging systems is on the rise. These cutting-edge imaging technologies provide researchers with the capability to perform comprehensive studies on various diseases, track their progression, assess the efficacy of treatments, and evaluate the safety and toxicity of novel drugs or therapies. This heightened emphasis on preclinical research is significantly contributing to the growth of the small animal imaging market.
Restraints in the Small Animal Imaging Market
The Small Animal Imaging market faces several constraints, notably the restricted availability of imaging agents. The process of developing and validating imaging agents specifically designed for preclinical studies can be both lengthy and expensive, which hinders their broader acceptance and use. This scarcity of suitable imaging agents can significantly affect the overall deployment of small animal imaging technologies within research environments, leading to potential delays in scientific progress and diminishing the effectiveness of preclinical studies. Consequently, this limitation may restrict researchers' ability to achieve comprehensive results, ultimately impacting the growth and application of the Small Animal Imaging market.
Market Trends of the Small Animal Imaging Market
The global small animal imaging market is witnessing a significant trend towards the increased adoption of multimodal imaging techniques, which integrate various imaging modalities to enhance the understanding of biological processes and disease progression in small animals. This trend is propelled by the demand for more precise and detailed imaging data in preclinical research and drug development. By utilizing a combination of techniques like positron emission tomography (PET), computed tomography (CT), magnetic resonance imaging (MRI), and optical imaging, researchers gain complementary insights that improve the sensitivity and specificity of imaging studies, ultimately fostering advancements in therapeutic efficacy and research outcomes.